Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report

Sinonasal squamous cell carcinoma (SNSCC) is the most common, high-aggressive sinonasal malignancies that have remained relatively stable poor outcomes over the past decade. As a first-line treatment for SNSCC, surgery plus adjuvant radiotherapy is recommended. However, complete surgical resection m...

Descripció completa

Dades bibliogràfiques

Autors principals:	Fang Chen, Hongzheng Zhang, Yonghe Li, Tingfeng Liang, Tao Zhang
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2024-07-01
Col·lecció:	Frontiers in Immunology
Matèries:	sinonasal squamous cell carcinoma tislelizumab immune checkpoint inhibitor immunotherapy pathological complete response
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1414529/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!